NEW YORK--(BUSINESS WIRE)--July 13, 2006--AXM Pharma, Inc. (OTC: AXMP - News), a manufacturer of proprietary and generic pharmaceutical and nutraceutical products for the Chinese and other Asian markets, announced today that it has appointed Steven M. Dinh Sc.D. to its Board of Directors. He replaced Wenzhou Zhang, who has resigned as a result of current Administrative Regulations of the People’s Republic of China Cadre that prevent him for serving on the Board. Mr. Zhang will continue to work with the Company as a consultant.
